Kiin Bio Weekly
Subscribe
Sign in
Home
Podcast
About
EMBL-EBI’s Enzyme Motif Miner, Arc Institute's RESPLICE, and Harvard’s MEDEA
Kiin Bio's Weekly Insights
READ THE LATEST
Weekly Newsletter
View all
EMBL-EBI’s Enzyme Motif Miner, Arc Institute's RESPLICE, and Harvard’s MEDEA
Kiin Bio's Weekly Insights
Feb 19
•
Natasha Kilroy
2
EPFL’s GLDP, UO's CyclicMPNN, and UHN’s EchoJEPA
Kiin Bio's Weekly Insights
Feb 12
•
Natasha Kilroy
Seoul National University’s FoldMason, NIH’s RNAnneal, and Harvard’s ARK
Kiin Bio's Weekly Insights
Feb 5
•
Natasha Kilroy
3
Absci’s Origin-1, JKU Linz’s MolecularIQ, and Genesis’s PEARL
Kiin Bio's Weekly Insights
Jan 29
•
Natasha Kilroy
1
Podcast
View all
17:20
Introducing Chai-2: A Breakthrough Framework for Zero-Shot Antibody Design
What’s slowing you down?
Jul 9, 2025
•
Kiin Bio
2
1
22:45
FutureHouse Introduces ether0: A Chemistry Reasoning Model for Molecular Design
FutureHouse has developed ether0, a 24B-parameter reasoning language model that solves complex chemistry problems by generating explicit, step-by-step…
Jun 6, 2025
1
1
19:14
Introducing Virtual Cells by Recursion: A New Framework for Predictive and Explainable Drug Discovery
Introducing Virtual Cells: A New Framework for Predictive and Explainable Drug Discovery
Jun 5, 2025
2
1
22:54
Introducing Robin: A Multi-Agent System for Automated Drug Discovery
Before we start … we are hiring for a few positions (bioinformatician, cheminformaticia, software engineer)!
May 22, 2025
4
1
Deep Dive
View all
⬡ SureChEMBL 2.0: Rebuilding Patent Chemistry for the AI Era
Deep Dive | Edition 14
Feb 11
•
Natasha Kilroy
3
1
🔬BinderFlow: Making Protein Binder Design Work in Real Labs
Deep Dive | Edition 13
Feb 4
•
Natasha Kilroy
2
🧬 Designing the Building Blocks of Life: A Primer on Structural Biology
What’s your biggest time sink in early drug discovery process?
Jan 28
•
Natasha Kilroy
2
🧬 MOLECULE: Why Protein Motion Changes How We Classify Drug Action
Deep Dive | Edition 12
Jan 14
•
Natasha Kilroy
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
